Mark Douglas Smith, Director at Jazz Pharmaceuticals plc (JAZZ), sold 417 shares at $119.27 ($50K) on 2023-12-04, disclosed to the SEC on 2023-12-06.
Open-market sale of $50k JAZZ by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TDOC | BUY | 2024-08-19 | $28K | — | Filing → |
| PHR | SELL | 2024-07-22 | $175K | — | Filing → |
| JAZZ | SELL | 2023-08-15 | $343K | — | Filing → |